0001209191-22-055548.txt : 20221103 0001209191-22-055548.hdr.sgml : 20221103 20221103170922 ACCESSION NUMBER: 0001209191-22-055548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221102 FILED AS OF DATE: 20221103 DATE AS OF CHANGE: 20221103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Byam Rebecca CENTRAL INDEX KEY: 0001866256 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40591 FILM NUMBER: 221359067 MAIL ADDRESS: STREET 1: C/O HCW BIOLOGICS, INC. STREET 2: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HCW Biologics Inc. CENTRAL INDEX KEY: 0001828673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825024477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 954-842-2024 MAIL ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-02 0 0001828673 HCW Biologics Inc. HCWB 0001866256 Byam Rebecca C/O HCW BIOLOGICS INC 2929 N. COMMERCE PARKWAY MIRAMAR FL 33025 0 1 0 0 Chief Financial Officer Common Stock 2022-11-02 4 M 0 33750 0.14 A 361702 D Stock Option Grant (Right to Buy) 0.14 2022-11-02 4 M 0 33750 0.00 D 2029-12-19 Common Stock 33750 47249 D These option shares were part of a stock option grant covering 135,000 shares of common stock. 20% of the total shares subject to the stock option grant vested on October 10, 2020; 20% of the total shares subject to the stock option grant vested on October 10, 2021; 25% of the total shares subject to the stock option grant will vest on October 10, 2022; and 35% of the total shares subject to the stock option grant will vest on October 10, 2023, subject to her continuous service through the applicable vesting date. The option is subject to additional vesting acceleration pursuant to her Employment Agreement. /s/ Rebecca A. Byam 2022-11-03